Company
Bio-Thera Solutions,Ltd.
Headquarters: Guangzhou, China
Employees: 836
CEO: Shegnfeng Li
Market Cap
CN¥8.68 Billion
CNY as of Jan. 1, 2025
US$1.19 Billion
Bio-Thera Solutions,Ltd. Categories
China Healthcare BiotechnologyChina Healthcare China Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $113.24 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $76.33 B |
| Marinomed Biotech AG | $56.13 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Bio-Thera Solutions, Ltd engages in the research and development of biosimilar therapeutics for the treatment of cancer, autoimmune, cardiovascular, and other serious medical conditions. It develops antibody therapeutics, such as BAT8001, BAT1306, BAT4306F, BAT5906, BAT8003, and BAT2094; and biosimilars, including BAT1406, BAT1706, BAT1806, and BAT2506. The company is based in Guangzhou, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥825.2 M |
| EBITDA | CN¥-391,512,032 |
| Gross Profit TTM | CN¥511.5 M |
| Profit Margin | -45.77% |
| Operating Margin | -70.94% |
| Quarterly Revenue Growth | 22.40% |
Stocks & Indices
Bio-Thera Solutions,Ltd. has the following listings and related stock indices.
Stock: SSE: 688177 wb_incandescent